Arcutis Biotherapeutics, Inc. (ARQT) Executive Compensation
Arcutis Biotherapeutics, Inc. (ARQT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARQT
CIK: 1787306
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerMark Montoya
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-15 | — | 144 Filing | 0001628280-26-065989 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-05 | — | SCHEDULE 13G/A Filing | 0002012383-26-003314 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062732 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001628280-26-062490 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001628280-26-062242 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001628280-26-062042 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001628280-26-061444 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001628280-26-060930 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-27 | FORM 4 | 0001628280-26-059444 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001628280-26-059254 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | FORM 4 | 0001628280-26-058648 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | FORM 4 | 0001628280-26-058420 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001628280-26-058275 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | FORM 4 | 0001628280-26-058008 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001628280-26-057973 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001628280-26-057390 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003443 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001628280-26-056898 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001628280-26-055797 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000413 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053755 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053754 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053753 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001787306-26-000051 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-07-31 | 8-K | 0001787306-26-000049 | View SEC Doc Filr Page |